XML 58 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments
12 Months Ended
Dec. 31, 2024
Financial Instruments  
Financial Instruments

29.

Financial Instruments

The following table sets forth the financial instruments, measured at fair value, by level within the fair value hierarchy as of December 31, 2023 (in thousands):

Fair Value Measurements

    

    

(RMB)

    

Quoted Prices in

Active Market

Significant Other

Significant

for Identical

Observable

Unobservable

Assets

Inputs

Inputs

    

Total

    

(Level 1)

    

(Level 2)

    

(Level 3)

Equity investments with readily determinable fair values

3,107,266

3,107,266

Short-term investments

 

4,436,057

 

4,436,057

Investments accounted for at fair values

 

490,781

490,781

Total

8,034,104

3,107,266

 

4,436,057

490,781

The following table sets forth the financial instruments, measured at fair value, by level within the fair value hierarchy as of December 31, 2024 (in thousands):

Fair Value Measurements

    

    

(RMB)

    

    

Quoted Prices in

Active Market

Significant Other

Significant

for Identical

Observable

Unobservable

Assets

Inputs

Inputs

    

Total

    

(Level 1)

    

(Level 2)

(Level 3)

Equity investments with readily determinable fair values

2,375,785

2,375,785

Short-term investments

 

10,756,143

 

10,756,143

Investments accounted for at fair values

241,570

241,570

Total

 

13,373,498

2,375,785

 

10,756,143

241,570

The rates of interest under the loan agreements with the lending banks were determined based on the prevailing interest rates in the market. The Group classifies the valuation techniques that use these inputs as Level 2 of fair value measurements of short-term bank loans. For other financial assets and liabilities with carrying values that approximate fair value, if measured at fair value in the financial statements, these financial instruments would be classified as Level 3 in the fair value hierarchy. As of December 31, 2023 and 2024, certain equity investments without determinable fair value (Note 11) were measured using significant unobservable inputs (Level 3) and written down from their respective carrying value to fair value, with impairment charges of RMB274.2 million and RMB1.0 billion incurred and recorded in earnings for the years then ended.